TY  - GEN
AU  - Myers,Andrea P
AU  - Konstantinopoulos,Panagiotis A
AU  - Barry,William T
AU  - Luo,Weixiu
AU  - Broaddus,Russell R
AU  - Makker,Vicky
AU  - Drapkin,Ronny
AU  - Liu,Joyce
AU  - Doyle,Austin
AU  - Horowitz,Neil S
AU  - Meric-Bernstam,Funda
AU  - Birrer,Michael
AU  - Aghajanian,Carol
AU  - Coleman,Robert L
AU  - Mills,Gordon B
AU  - Cantley,Lewis C
AU  - Matulonis,Ursula A
AU  - Westin,Shannon N
TI  - Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer
SN  - 1097-0215
PY  - 2021///0308
KW  - Adult
KW  - Aged
KW  - Class I Phosphatidylinositol 3-Kinases
KW  - genetics
KW  - Drug Administration Schedule
KW  - Endometrial Neoplasms
KW  - drug therapy
KW  - Female
KW  - Heterocyclic Compounds, 3-Ring
KW  - administration & dosage
KW  - Humans
KW  - Middle Aged
KW  - Mutation
KW  - Neoplasm Recurrence, Local
KW  - Precision Medicine
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/ijc.32783
ER  -